EP2254570
Samband sem felur í sér paklítaxel til meðferðar á krabbameini í eggjastokkum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
19.2.2009EP published:
18.12.2013EP application number:
09712334.3
EP translation filed:
27.1.2014Grant published:
15.2.2014EPO information:
European Patent Register
Max expiry date:
18.2.2029Expiry date:
18.2.2016
Title:
COMBINATION COMPRISING PACLITAXEL FOR TREATING OVARIAN CANCER
Timeline
Today
19.2.2009EP application
18.12.2013EP Publication
27.1.2014Translation submitted
15.2.2014Registration published
18.2.2016Expires
Owner
Name:
Actelion Pharmaceuticals Ltd.Address:
Gewerbestrasse 16, 4123, Allschwil, CH
Inventor
Name:
CLOZEL, MartineAddress:
Binningen, CH
Name:
REGENASS, UrsAddress:
Allschwil, CH
Agent
Name:
Reynaldsson Patent ConsultingAddress:
Pósthólf 48, 212, Garðabæ,
Priority
Number:
PCT/IB2008/050607Date:
20.2.2008Country:
WO
Classification
Categories:
A61K 31/216, A61K 31/513, A61K 45/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 12.2.2014
Expires: 18.2.2015
Payer: G. H. Sigurgeirsson
Number: 7
Paid: 21.1.2015
Expires: 18.2.2016
Payer: G. H. Sigurgeirsson